TY - GEN
T1 - GPU-Accelerated Drug Discovery with Docking on the Summit Supercomputer
T2 - 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
AU - Legrand, Scott
AU - Scheinberg, Aaron
AU - Tillack, Andreas F.
AU - Thavappiragasam, Mathialakan
AU - Vermaas, Josh V.
AU - Agarwal, Rupesh
AU - Larkin, Jeff
AU - Poole, Duncan
AU - Santos-Martins, Diogo
AU - Solis-Vasquez, Leonardo
AU - Koch, Andreas
AU - Forli, Stefano
AU - Hernandez, Oscar
AU - Smith, Jeremy C.
AU - Sedova, Ada
N1 - Publisher Copyright:
© 2020 ACM.
PY - 2020/9/21
Y1 - 2020/9/21
N2 - Protein-ligand docking is an in silico tool used to screen potential drug compounds for their ability to bind to a given protein receptor within a drug-discovery campaign. Experimental drug screening is expensive and time consuming, and it is desirable to carry out large scale docking calculations in a high-Throughput manner to narrow the experimental search space. Few of the existing computational docking tools were designed with high performance computing in mind. Therefore, optimizations to maximize use of high-performance computational resources available at leadership-class computing facilities enables these facilities to be leveraged for drug discovery. Here we present the porting, optimization, and validation of the AutoDock-GPU program for the Summit supercomputer, and its application to initial compound screening efforts to target proteins of the SARS-CoV-2 virus responsible for the current COVID-19 pandemic.
AB - Protein-ligand docking is an in silico tool used to screen potential drug compounds for their ability to bind to a given protein receptor within a drug-discovery campaign. Experimental drug screening is expensive and time consuming, and it is desirable to carry out large scale docking calculations in a high-Throughput manner to narrow the experimental search space. Few of the existing computational docking tools were designed with high performance computing in mind. Therefore, optimizations to maximize use of high-performance computational resources available at leadership-class computing facilities enables these facilities to be leveraged for drug discovery. Here we present the porting, optimization, and validation of the AutoDock-GPU program for the Summit supercomputer, and its application to initial compound screening efforts to target proteins of the SARS-CoV-2 virus responsible for the current COVID-19 pandemic.
KW - Drug discovery
KW - GPU acceleration
KW - high-performance computing
KW - protein-ligand docking
UR - http://www.scopus.com/inward/record.url?scp=85096991107&partnerID=8YFLogxK
U2 - 10.1145/3388440.3412472
DO - 10.1145/3388440.3412472
M3 - Conference contribution
AN - SCOPUS:85096991107
T3 - Proceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
BT - Proceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
PB - Association for Computing Machinery, Inc
Y2 - 21 September 2020 through 24 September 2020
ER -